Video to Promote HPV Vaccination
Educating Pre/Teens and Their Parents on the Importance of HPV Vaccination
研究概览
详细说明
Human Papillomavirus (HPV) is a common sexually transmitted infection that has the potential to cause cancer. The vaccine is recommended because it prevents the HPV infections that most commonly cause cancer. HPV vaccines offer the best protection to girls and boys who receive the complete, three-vaccine series and have time to develop an immune response before being exposed to HPV. However, vaccination rates are low compared to other vaccines for teens.
Results from this study will help us learn why participants do or do not get the HPV vaccination and whether video-based education can help improve vaccination rates
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
Pennsylvania
-
Flourtown、Pennsylvania、美国、19031
- Primary Care, Flourtown, Children's Hospital of Philadelphia
-
Philadelphia、Pennsylvania、美国、19139
- Nicholas and Athena Karabots Pediatric Care Center
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Parent-child dyads in which the child is a male or female age 11 to 17 years who has not received the HPV vaccine
Exclusion Criteria:
- Parent-child dyads in which the child has received the HPV vaccine
- Parent-child dyads in which the child is older than 18 at the time of enrollment
- Non-English speakers
学习计划
研究是如何设计的？
设计细节
- 主要用途：其他
- 分配：随机化
- 介入模型：并行分配
- 屏蔽：无（打开标签）
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
无干预：Vaccine Information Statement
Study participants will receive the HPV Vaccine Information Statement (VIS) which is part of routine care.
|
|
|
实验性的：Video & Vaccine Information Statement
Participants will view an educational video about the HPV vaccine with a male or female narrator.
Participants will also receive the HPV Vaccine Information Statement (VIS) which is part of routine care.
|
Participants will watch an educational video about the quadrivalent HPV vaccine (Gardasil) narrated by either a male or female.
|
研究衡量的是什么？
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
HPV Vaccination Series Initiation
大体时间：90 days
|
Number of HPV vaccine doses received among study participants
|
90 days
|
|
HPV Vaccine Series Initiation
大体时间：0 days
|
HPV Vaccine Receipt among study participants
|
0 days
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
HPV Vaccine Series Initiation (depending on male versus female narrator)
大体时间：0 days
|
Difference in rate of HPV vaccine receipt between study participants who viewed a video narrated by a male versus a female
|
0 days
|
|
HPV Vaccine Series Initiation (depending on male versus female narrator)
大体时间：90 days
|
Difference in number of HPV vaccine doses between study participants who viewed a video narrated by a male versus a female
|
90 days
|
其他结果措施
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
HPV Vaccine Awareness
大体时间：0 days
|
Reported reason for HPV vaccine receipt or deferral
|
0 days
|
合作者和调查者
调查人员
- 首席研究员：Kristen A. Feemster, MD MPH MSHP、Children's Hospital of Philadephia
研究记录日期
研究主要日期
学习开始
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.